Table 3.
Odds Ratios of LGA (>90th Percentile) | ||||
---|---|---|---|---|
Quartiles | Se Levels (µg/L) | LGA/AGA | OR * (95% CI); p *** | AOR * (95% CI); p ** |
Whole group
(N = 330) |
||||
Q1 | 42.69–55.88 | 21/61 | 2.51 (1.10–5.74); 0.029 | 3.00 (1.26–7.15); 0.013 |
Q2 | 55.88–61.16 | 20/63 | 2.32 (1.01–5.32); 0.047 | 2.41 (1.02–5.67); 0.044 |
Q3 | 61.16–66.01 | 15/67 | 1.63 (0.69–3.89); 0.266 | 1.71 (0.71–4.15); 0.234 |
Q4 | 66.01–125.54 | 10/73 | 1 *** | 1 *** |
Women with the normal BMI
(N = 145) # |
||||
Q1 | 42.68–58.27 | 11/25 | 3.63 (1.03–12.76); 0.044 | 4.79 (1.13–20.26); 0.033 |
Q2 | 58.27–61.86 | 8/28 | 2.36 (0.64–8.66); 0.197 | 3.00 (0.74–12.28); 0.126 |
Q3 | 61.86–67.69 | 4/32 | 1.03 (0.24–4.48); 0.967 | 1.46 (0.30–7.09); 0.635 |
Q4 | 67.69–89.17 | 4/33 | 1 *** | 1 *** |
Women with a male fetus
(N = 176) |
||||
Q1 | 44.39–56.32 | 16/28 | 4.42 (1.36–14.34); 0.013 | 6.26 (1.79–22.05); 0.004 |
Q2 | 56.32–61.46 | 8/36 | 1.82 (0.52–6.32); 0.347 | 1.97 (0.56–7.02); 0.293 |
Q3 | 61.46–67.32 | 8/36 | 1.94 (0.55–6.83); 0.301 | 2.32 (0.64–8.45); 0.200 |
Q4 | 67.32–125.54 | 5/39 | 1 *** | 1 *** |
! Selenium concentrations were measured in the serum from the 10–14th week, and border values were included in the lower quartile; * OR: crude odds ratios calculated in the univariate logistic regression in matched groups and AOR: adjusted odds ratio calculated in the multivariate logistic regression after adjusting for maternal height, gestational weight gain per week, and prior fetal macrosomia; ** p-value obtained using the Wald test (p < 0.05 was considered to be significant); *** the reference quartile with the lowest number of LGA cases (OR/AOR = 1.00); CI: confidence intervals; LGA cases (mothers delivering to newborn > 90th percentile); AGA controls (mothers delivering to newborn between the 10th and 90th percentile). # Subgroup of the normal pre-pregnancy body mass index: 18.50–24.99 kg/m2.